Teva UK Limited has launched the first generic co-beneldopa capsules in a variety of strengths. Co-beneldopa is a dopaminergic drug indicated for treatment of symptoms of Parkinson's disease. It is a generic version of Madopar(R) (co- beneldopa) made by Roche. It is available immediately in the award-winning Teva 360 livery, which is designed to aid patient safety.
No comments:
Post a Comment